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The embryonic stem cell (ESC) transcriptional and
epigenetic networks are controlled by a multilayer
regulatory circuitry, including core transcription
factors (TFs), posttranscriptional modifier micro-
RNAs (miRNAs), and some other regulators.
However, the role of large intergenic noncoding
RNAs (lincRNAs) in this regulatory circuitry and their
underlying mechanism remains undefined. Here, we
demonstrate that a lincRNA, linc-RoR, may function
as a key competing endogenous RNA to link the
network of miRNAs and core TFs, e.g., Oct4, Sox2,
and Nanog. We show that linc-RoR shares miRNA-
response elements with these core TFs and that
linc-RoR prevents these core TFs frommiRNA-medi-
ated suppression in self-renewing human ESC. We
suggest that linc-RoR forms a feedback loop with
core TFs and miRNAs to regulate ESC maintenance
and differentiation. These results may provide
insights into the functional interactions of the
components of genetic networks during develop-
ment and may lead to new therapies for many
diseases.
INTRODUCTION
Embryonic stem cells (ESCs) have an unlimited potential to be
propagated in culture in an undifferentiated state (self-renewal)
and the ability to generate and differentiate into most cell types
(pluripotency) (Okita et al., 2007). The transcriptional and epige-
netic networks controlling ESC self-renewal and pluripotency are
the focus of intense interest, because of their obvious thera-
peutic potential as well as exceptional relevance to models of
early development (Sheik Mohamed et al., 2010; Young, 2011).
It has been well established that a group of core transcription
factors (TFs), e.g., Oct4, Sox2, and Nanog, play a critical role
in the transcriptional network by promoting the expression of
ESC-specific genes and by suppressing differentiation (Boyer
et al., 2005; Chen et al., 2008; Kim et al., 2008). The key role ofDthe core TFs was highlighted by the fact that the exogenous
introduction of these TFs into murine or human adult cells
induced pluripotency by reprogramming these cells into induced
pluripotent stem cells (iPSCs), which are functionally and pheno-
typically similar to ESCs (Okita et al., 2007; Yu et al., 2007).
For posttranscriptional networks, microRNAs (miRNAs),
a type of small noncoding RNA that posttranscriptionally regu-
lates gene expression, are also well known as the key posttran-
scriptional modifier contributing to the control of hESC self-
renewal, pluripotency (Melton and Blelloch, 2010; Melton et al.,
2010), and differentiation (Morin et al., 2008). A handful of
miRNAs have been reported to be involved in the direct repres-
sion of these core TFs; miR-145 represses the 30 UTR of Oct4,
Sox2, and Klf4 (Xu et al., 2009). MiR-134, miR-296, and miR-
470 target the coding DNA sequence (CDS) of mouse NANOG,
OCT4, and SOX2 (Tay et al., 2008). The temporal upregulation
of thesemiRNAsmay be necessary and sufficient to repress plu-
ripotency and control ESC differentiation, which was also
confirmed by the fact that ESCs deficient in miRNA-processing
enzymes, such as Dicer and DCGR8, show defects in differenti-
ation (Kanellopoulou et al., 2005; Murchison et al., 2005; Wang
et al., 2007). However, in contrast to our understanding of the
miRNA-mediated regulation of core TFs, it remains unclear
whether components of the transcriptional and posttranscrip-
tional networks functionally modulate the expression of miRNAs
and which factors might mediate such regulation. The lack of
such information may impair the balance of the current model
of the regulatory circuitry in human embryonic stem cells
(hESCs). We hypothesize that the characterization of these
miRNA regulatory factors may be of great importance to under-
stand the regulation of ESC self-renewal and pluripotency.
In addition tomiRNA, long or large intergenic noncoding RNAs
(lincRNAs) have recently been identified as novel regulators of
the transcriptional and epigenetic networks (Mercer et al.,
2009). A number of recent papers have revealed that lincRNA
are important and powerful cis- and trans-regulators of gene
activity that can function as scaffolds for chromatin-modifying
complexes and nuclear bodies and as enhancers and mediators
of long-range chromatin interactions (Huarte et al., 2010; Khalil
et al., 2009). Interestingly, several recent reports have provided
a model that suggests that lincRNA may function as competing
endogenous RNA (ceRNA) in modulating the concentration and
biological functions of miRNAs (Cesana et al., 2011; Tay et al.,evelopmental Cell 25, 69–80, April 15, 2013 ª2013 Elsevier Inc. 69
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a ceRNA that protects PTEN messenger RNA (mRNA) from
miRNA-mediated degradation (Tay et al., 2011). Linc-MD1 has
also been identified as a ceRNA that protects MyoD transcripts
(Cesana et al., 2011). These ceRNAs generally share miRNA-
response elements with the transcripts of several important
genes and prevent these mRNAs from being degraded. We
therefore propose that some lincRNAs may also have roles as
ceRNAs to link the miRNAs and transcriptional network in
hESCs. However, the role of ceRNAs in the process of pluripo-
tency regulation has not yet been elucidated.
In our current work, which seeks to determine the ceRNAs
regulating hESC self-renewal and differentiation, we investigated
a large intergenic noncoding RNA, linc-RoR, which was previ-
ously identified as a key reprogramming regulator and whose
expression is linked to pluripotency under the direct regulation
of core pluripotency TFs (Loewer et al., 2010). However, the
functions of and mechanisms utilized by linc-RoR in the process
of ESC self-renewal and differentiation have not been fully eluci-
dated. In our current study, based on bioinformatic and experi-
mental approaches, we suggest that linc-RoR functions as
a ceRNA to regulate the expression of core TFs OCT4, SOX2,
and NANOG and differentiation-related miRNAs in hESCs.
RESULTS
Linc-RoR Expression Is Positively Correlated with the
Undifferentiated ES Cell State
To identify the mechanism of linc-RoR-mediated regulation in
hESCs, we began by assessing the expression levels and loca-
tion of linc-RoR in hESCs (H1 and X-01 [Wu et al., 2011] cells)
growing under self-renewal conditions and various differentiated
conditions, including the removal of fibroblast growth factor
(bFGF), bone morphogenetic protein (BMP) 4-induction, or
embryoid body (EB) formation. Employing a fluorescence
in situ hybridization (FISH) assay, we found that the linc-RoR
transcripts were abundant in the cytoplasm of self-renewing
hESC cells (H1, 40 passages; X-01, 30 passages) (Figure 1A),
which supports the hypothesis that linc-RoR interacted with
miRNAs in the cytoplasm. However, we did not detect linc-
RoR expression in differentiated hESCs in FISH assays. In
a qRT-PCR analysis, a marked reduction of linc-RoR transcripts
was observed in all differentiated hESCs, which indicated that
linc-RoR expression is positively correlated with the undifferen-
tiated ESC state (Figure 1B). Additionally, when we depleted
Oct4 or Nanog with small interfering RNAs (siRNAs), we
observed a reduction in linc-RoR in hESC H1 cells (Figure 1C)
and X-01 cells (Figure S1A available online), compared with the
control RNA-transfected cells. Furthermore, a chromatin immu-
noprecipitation (ChIP) assay confirmed that Oct4, Nanog, and
Sox2 were present in the promoter region of linc-RoR during
hESC H1 self-renewal but not during differentiation (Figure 1D).
These data are consistent with previous reports (Loewer et al.,
2010) and confirm that the linc-RoR gene is a direct target of
core TFs.
To further reveal the dynamic changes of linc-RoR expression
during the hESC differentiation process, we examined linc-RoR
and core TF mRNA levels with quantitative real-time PCR at
different time points. Linc-RoR was expected to be downregu-70 Developmental Cell 25, 69–80, April 15, 2013 ª2013 Elsevier Inc.lated after Oct4, Nanog, and Sox2 reduction because its tran-
scription is under the control of these core TFs. In our study,
quantitative real-time PCR showed that the expression levels
of linc-RoR and core TFs changed synchronously in hESC line
H1 (Figure 1E) and X-01 (Figure S1B) cells. Interestingly,
however, the expression of linc-RoR rapidly decreased (90%
on the second day) under the differentiation conditions, which
changed prior to the decline in levels of these core TFs (no
more than 30% on the fourth day). We therefore hypothesize
that linc-RoR may also regulate Oct4, Nanog, or Sox2 expres-
sion in hESCs, which signifies the role of linc-RoR in the pluripo-
tency-regulating networks.
Linc-RoR Regulates Endogenous Oct4, Nanog, and Sox2
Expression in Self-Renewing and Differentiating hESCs
To further confirm that linc-RoR regulates Oct4, Nanog, or Sox2
expression in hESCs, we next investigated whether ectopic linc-
RoR affected expression of these core TFs in hESCs under self-
renewal conditions or differentiation condition. Toward this end,
we constructed a linc-RoR-overexpressing vector and trans-
fected it into undifferentiated hESCs to isolate the GFP-positive
(GFP+) hESC population that expressed the vector-encoded
GFP by fluorescence-activated cell sorting (FACS) (Figure S2A).
We found that linc-RoR increased more than 40-fold compared
with the vector-transfected hESCs. At the same time, the tran-
sient overexpression linc-RoR also elevated core TFs mRNA
and protein expression in two hESC lines under self-renewing
conditions (Figures 2A and S2C) or even under differentiation
conditions (Figures 2B andS2D).We also employed a fluorescein
isothiocyanate (FITC)-labeled linc-RoR-specific siRNA (siROR)
to reduce the endogenous linc-RoR in hESCs with an FITC-
labeled scrambled sequence with no homology to the human
genome in parallel as a negative control (NC RNA). Three days
after transfection, we isolated the FITC-positive hESC H1 popu-
lation for quantitative real-time PCR analysis (Figure S2B). The
level of linc-RoR RNA was decreased by more than 70% at the
third day after siROR transfection, compared with NC RNA.
Furthermore, we found that the mRNA and protein expression
of Oct4 and Nanog was decreased in linc-RoR-deficient hESCs
after 3 days under self-renewal conditions (Figures 2C and S2E).
The mRNA expression level of Sox2, but not its protein expres-
sion level, significantly changed during this process. In differen-
tiating hESCs, we also found that siROR resulted in a more
intense reduction of the core TFs than NC RNA (Figures 2D
and S2F). These data indicate that linc-RoR positively regulates
expression of core TFs in two hESC lines. Considering the facts
that core TFs also directly regulate linc-RoR transcription, we
therefore suggested that linc-RoR and core TFs formed a regula-
tory feedback loop in hESCs.
Linc-RoR Regulated Expression of Core TFs Mainly
through a MicroRNA-Dependent Mechanism in hESCs
We then evaluated the molecular mechanism for the linc-RoR-
mediated regulation of Oct4, Nanog, and Sox2 expression.
Because of the chromosome-modifying functions of many other
reported lincRNAs, we first evaluated whether linc-RoR could
also promote Oct4, Nanog, and Sox2 de novo transcription.
However, using a reporter vector containing the Oct4-promoter,
we found that neither ectopic linc-RoR nor linc-RoR siRNA
Figure 1. Linc-RoR Expression Is Positively Correlated with the Undifferentiated ES Cell State
(A) The in situ expression of linc-RoR RNA in the self-renewing hESC lines H1 and X-01. The green fluorescent signal is from the FITC-linc-RoR RNA probe, and
the blue fluorescent signal is from nuclear DNA counterstained with DAPI. The scale bar represents 10 or 50 mm.
(B) The relative level of linc-RoR increased after hESC differentiation in qRT-PCR analysis. The blots from an electrophoresis assay are shown, and GAPDH was
used as an internal normalization control. EB, embryoid bodies. Data are represented as mean ± SEM. **p < 0.01, n = 3.
(C) The relative level of linc-RoR decreased in hESCs 3 days after the transfection of siRNAs (si) targeting OCT4 or NANOG. The interfering efficiency was
confirmed with quantitative real-time PCR. Data are represented as mean ± SEM. **p < 0.01, n = 3.
(D) ChIP showed highOct4, Nanog, and Sox2 enrichment at the linc-RoR promoter in hESCs but not in cells after bFGF removal for 7 days on. Relative enrichment
is normalized to control IgG. The positions of the PCR amplicon are labeled according to information from the Web site of the University of California, Santa Cruz
Genome Browser (http://genome.ucsc.edu/). Data are represented as mean ± SEM. **p < 0.01, n = 3.
(E) The kinetic expression levels of linc-RoR, NANOG, SOX2, and OCT4 in differentiated H1 cells by withdrawal of bFGF. The relative expression levels of RNA
were quantified by quantitative real-time PCR and were normalized to GAPDH.
Data are represented as mean ± SEM. See also Figure S1.
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hESCs under self-renewal or differentiation conditions (Fig-
ure S2G). These results indicate that linc-RoR does not regulate
Oct4 at the transcriptional level but may regulate them at the
posttranscriptional level.
As one of the most important posttranscriptional modifiers,
miRNAs have been shown to be critical regulatory factors during
hESC differentiation. We therefore evaluated the expression of
linc-RoR and core TFs in Dicer-deficient ESCs, which have
impaired global miRNAs expression. The lentivirus (LV)-short
hairpin (sh) RNA-mediated knockdown of Dicer mRNA and
protein expression in hESCs was confirmed by comparison
with LV-scrambled short hairpin RNA controls (LV-NC) (Fig-
ure 2E). Both in the self-renewing (Figure 2E) and differentiated
hESCs (Figure 2F), we found that Dicer knockdown partially
rescued the reduction of core TFs induced by linc-RoR knock-
down, whereas the control lentivirus-infected cells had changesDsimilar to uninfected cells. These results support our hypothesis
that miRNAs play essential roles in the linc-RoR-mediated regu-
lation of core TFs expression in hESCs.
Linc-RoR Shares Regulatory miRNAs with the Core TFs
Oct4, Sox2, and Nanog
To investigate the miRNA-related functions of linc-RoR in
ESCs, we sought to functionally characterize specific regula-
tory miRNAs in the maintenance of ES cell self-renewal and
differentiation with a particular focus on the core TFs Oct4,
Sox2, and Nanog. Thus, we mined previously published micro-
array data (Ivanova et al., 2006) for miRNAs elevated during
hESCs differentiation and confirmed the expression levels of
these miRNAs in differentiated hESCs (Figure S3A), linc-RoR-
overexpressing or knockdown hESCs, and Oct4 knockdown
hESCs (Figure S3C). Several miRNAs, including miR-145,
miR-181a, miR-99a, and let-7a, were found greatly elevatedevelopmental Cell 25, 69–80, April 15, 2013 ª2013 Elsevier Inc. 71
Figure 2. Linc-RoR Regulates Oct4, Nanog, and Sox2 Expression in Self-Renewing hESCs
(A and B) Relative mRNA and protein levels of OCT4, SOX2, and NANOG in hESCs under self-renewal (A) or differentiation (B) conditions that were transfected
with linc-RoR-overexpressing vector (linc-RoR) or control vector (vector). The GFP-positive hESCs were isolated by FACS.
(C and D) Relative mRNA and protein levels of OCT4, SOX2, and NANOG in hESCs under self-renewal (C) or differentiation (D) conditions that were transfected
with siRNA targeting linc-RoR (siROR) or negative control RNA (NC).
(E and F) Dicer deficiency rescued the siROR-mediated reduction of linc-RoR,OCT4, SOX2, andNANOGmRNA in hESCs under self-renewal (E) or differentiation
(F) conditions. The interfering efficiency of a lentivirus encoding Dicer-targeting shRNA (LV-shDicer) was also confirmed comparing to negative control lentivirus
(LV-NC). RNA and protein levels were assayed by quantitative real-time PCR and western blot analysis; GAPDH is the normalization control.
Data are represented as mean ± SEM. **p < 0.01, n = 3. See also Figure S2.
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hESCs. As miRNAs may also bind the elements in CDS regions
besides 30 UTR (Tay et al., 2008), we used the bioinformatics
tool Miranda (Enright et al., 2003) to search for miRNAs that
target the full-length transcripts of Oct4, Sox2, and Nanog
and linc-RoR (Table S1). Of the miRNA that fit these criteria,
three families of miRNAs—miR-145, miR-181, and miR-99—
emerged as obvious candidates because their predicted
binding sites were shared by linc-RoR and core TFs (Figure 3A).
In addition, all three of these miRNAs have been reported to72 Developmental Cell 25, 69–80, April 15, 2013 ª2013 Elsevier Inc.functionally regulate hESC self-renewal (Kane et al., 2012; Xu
et al., 2009).
To validate the direct binding ability of the predicted miRNA-
response elements on these transcripts, we next performed an
RNA immunoprecipitation (RIP) analysis with MS2 binding
protein (MS2bp), which specifically binds RNA containing
MS2-binding sequences (MS2bs) when they are coexpressed.
We constructed vectors expressing linc-RoR, OCT4, SOX2, or
NANOG full-length transcripts combined with MS2bs elements
and cotransfected them into HEK293 cells with an MS2bp-YFP
Figure 3. Linc-RoR Shared Regulatory
MicroRNAs with the Core TFs Oct4, Sox2,
and Nanog and Prevented Them from Being
Suppressed
(A) The prediction for miRNA-binding elements on
linc-RoR, OCT4, NANOG, and SOX2 transcripts
by Miranda.
(B) The binding ability of linc-RoR,OCT4,NANOG,
and SOX2 full-length transcripts to miRNAs, which
were precipitated by cDNA combined with MS2-
binding sequences (MS2bs) and its binding
protein MS2BP-YFP. The immunoprecipitated
miRNAs were assayed by quantitative real-time
PCR and normalized to U6; MS2bs-RL and miR-
16 were used as negative controls. RL, Renilla
luciferase.
(C–E) The target validation using luciferase
reporters in HEK293 cells. The relative luciferase
activities of luciferase reporters containing wild-
type (WT) or mutant (Mut) transcripts were as-
sayed 48 hr after cotransfection with the indicated
microRNAs or scramble negative control RNA
(NC). Luc, firefly luciferase; pA, polyadenylation
signal; Control, the basal luciferase reporter
without inserts. (D) Comparison summary of miR-
145 target sites in the mRNA of linc-RoR, OCT4,
NANOG, and SOX2. The red nucleotides (target
sites) were deleted in the mutant constructs.
(F) Linc-RoR facilitated miR-145 degradation.
MiRNA levels were assayed by quantitative real-
time PCR in HEK293 cells cotransfected with
different concentrations of miR-145 mimics and
WT or mutant linc-RoR. MiR-16 was used as
a negative control.
(G) Coexpression of wild-type linc-RoR rescued
the relative luciferase activities of luciferase
reporters containing OCT4, NANOG, and SOX2
when cotransfected with miR-145. Blank vector
(vector) and mutant linc-RoR were used as
controls.
Data are represented as mean ± SEM. **p < 0.01,
n = 3. See also Figure S3 and Table S1.
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miR-181a, andmiR-99b—withmiR-16 as a negative control. The
transcript-specific binding RNA-protein complexes were then
immunoprecipitated with YFP antibody, and immunoglobulin
G (IgG) was used as a negative control. We performed quantita-
tive real-time PCR and found that miR-145-5p, miR-181a-5p,
and miR-99b-3p were enriched in MS2bs-linc-RoR-binding
RNAs and that OCT4, SOX2, and NANOG directly bound one
or two of the three miRNAs compared with the negative control
MS2BS-Renilla luciferase (RL) RNA (Figure 3B). In addition,
Argonaute 2 (Ago2) enrichment was observed in the RNA binding
proteins of MS2BS-linc-RoR, MS2BS-Oct4, MS2BS-Nanog,
and MS2BS- Sox2, compared with MS2BS-RL RNA (Fig-
ure S3B), which indicates that linc-RoR is recruited to Ago2-
related RNA-induced silencing complexes (RISCs) (Chi et al.,
2009) and functionally interacts with miRNAs.Developmental Cell 25, 69For further confirmation, we also con-
structed luciferase reporters containing
linc-RoR, Oct4, Nanog, or Sox2 full-length transcripts for targets investigations. We found that the
miR-145-5p mimics greatly reduced the luciferase activities of
the reporter vectors containing linc-RoR, Oct4, Nanog, or
Sox2, whereas the miR-181a-5p and miR-99b-3p mimics only
inhibited the linc-RoR reporter vector but exhibited weak
suppression effects (no more than 30%) on the three reporter
vector genes in comparison to the negative controls both in
HEK293 cells (Figure 3C) and H1 cells (Figure S3E). We therefore
chose miR-145 as a model miRNA for further studies. To avoid
nonspecific binding, we also constructed control transcripts
with mutations (Mut) in these miR-145 binding sites (miR-
145bs) (Figures 3D and 3E). We found that these mutations
partially abolished the effect of miR-145 on wild-type transcripts
in HEK293 cells (Figure 3E) and differentiated hESCs (Fig-
ure S3G). These data suggest that linc-RoR shares regulatory
miRNAs with the core TFs Oct4, Sox2, and Nanog and that–80, April 15, 2013 ª2013 Elsevier Inc. 73
Figure 4. linc-RoR Functions as an Endoge-
nous miR-145 Sponge in hESCs
(A and B) The expression levels of mature miR-145
and its primary (pri-) or premature (pre) transcripts
in self-renewing hESCs transiently transfected
with wild-type (WT) linc-RoR or mutant (Mut) linc-
RoR overexpressing vectors or linc-RoR-specific
siRNA (siROR). Blank vector or negative control
RNA (NC) was used as controls.
(C–F) The kinetic expression levels of linc-RoR,
mature miR-145, its primary (pri-) or premature
(pre) transcripts in nontransfected differentiated
hESCs transfected with WT linc-RoR or Mut linc-
RoR overexpressing vectors, blank vector, or
nothing. The relative expression levels of RNA
were quantified by quantitative real-time PCR and
normalized to GAPDH.
Data are represented as mean ± SEM. **p < 0.01,
n = 3. See also Figure S4.
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genes.
Linc-RoR Prevents Oct4, Sox2, and Nanog from miRNA-
Mediated Degradation
Because linc-RoR functionally recruited Ago2 and RISC
complexes, we next hypothesized that linc-RoR could have the
ability to influence miR-145 expression in ES cells. We engi-
neered linc-RoR-overexpressing plasmids that have either
wild-type (WT) or mutant (Mut) transcripts with mutations in the
two miR-145-binding sites. We found that the ectopically ex-
pressed linc-RoR WT reduced the concentration of miR-145
during the cotransfection of the linc-RoR expression vector
and low concentration of miRNA mimics in HEK293 cells (Fig-
ure 3F). As expected, linc-RoR Mut failed to reduce miRNA
expression, which indicated that the inhibition was sequence
specific. However, no significant effect was observed when the
ectopic linc-RoR was cotransfected with a high concentration
of miRNA mimics, which further demonstrated that the linc-
RoR-mediated suppression was saturable in vivo (Figure 3F).
We also found that linc-RoR expression levels were decreased
after transfection of miR-145 mimics, which indicated that both
miR-145 and linc-RoR were cleaved and degraded during this
process (Figure S3D). Taken together, these data suggest that
linc-RoR functions as an miRNA sponge to reduce the efficient
concentration of miR-145.74 Developmental Cell 25, 69–80, April 15, 2013 ª2013 Elsevier Inc.To further investigate whether linc-RoR
could protect Oct4, Nanog, or Sox2 from
miR-145-mediated suppression, we
cotransfected HEK293 cells or hESCs
with the linc-RoR-overexpressing vector
and the luciferase reporters containing
Oct4, Nanog, or Sox2 full-length tran-
scripts in the presence of miR-145
mimics or NC RNA. We found that
ectopic linc-RoRWT efficiently abolished
the miR-145-induced reduction of lucif-
erase activities in the Oct4, Nanog, and
Sox2 reporter vector-transfected cells,whereas ectopic expression of linc-RoR Mut failed to protect
the reporters from suppression similar to the negative control
vectors (Figures 3G and S3F). These results indicate that linc-
RoR protects the transcripts of the core TFs Oct4, Sox2, and
Nanog from miRNA-mediated degradation, both in an HEK293
cell-based model and hESCs.
Linc-RoR Functions as an Endogenous miR-145 Sponge
in hESCs
Next, we investigated the regulatory role of linc-RoR in the
expression of miR-145 in hESCs. We transiently elevated linc-
RoR expression with a linc-RoR-overexpressing vector or in-
hibited its expression by siROR in two self-renewal hESC lines.
To avoid nonspecific binding and effort, linc-RoR Mut, with
mutations on its miR-145-binding sites, was also employed as
a control. As shown in Figures 4A and 4B (H1 cells) and Figures
S4A and S4B (X-01 cells), the expression levels of mature miR-
145 were inversely associated with the expression levels of
linc-RoR WT, but not linc-RoR Mut, which indicates that linc-
RoR negatively regulates miR-145 through specific binding sites
(Figures 4A and S4A). To determine whether linc-RoR influenced
the miRNA transcription and mature processes, we also
analyzed primary (pri-) and premature (pre-) transcripts of miR-
145. Interestingly, inconsistent with mature miR-145 levels, the
changes of pri-miR-145 and pre-miR-145 were not significant
after treatments, which indicated that linc-RoR mainly regulates
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mechanism (Figures 4A, 4B, S4A, and S4B).
Because endogenous linc-RoR greatly decreased during
hESC differentiation, we next investigated the dynamic expres-
sion levels of linc-RoR and miR-145 in differentiated hESCs after
bFGF removal. As shown in Figure 4C, the expression levels of
pri-miR-145 and pre-miR-145 gradually increased from the first
day after ESC differentiation. However, the expression level of
mature miR-145 was slightly increased in the first 2 days but
greatly increased 3 days after differentiation, whereas linc-RoR
had been greatly decreased, which indicated that mature miR-
145 may not increase greatly in the presence of linc-RoR. We
also transfected hESCs with linc-RoRWT or linc-RoR-Mut-over-
expressing vectors 6 hr prior to bFGF removal (Figures 4D–4F).
We found that ectopic linc-RoR WT suppressed the elevation
of mature miR-145 in first 3 days, whereas pri- and pre-miR-
145 gradually increased at the same time. After 5 days, mature
miR-145 started to increase when linc-RoR levels had signifi-
cantly decreased (Figure 4D). Neither linc-RoR Mut (Figure 4F)
nor blank vector (Figure 4E) induced such phenomenon in our
assays. These results indicate that linc-RoR functions as an
endogenous miR-145 sponge to avoid miR-145 increases in
self-renewing hESCs.
To serve as a sponge, the abundance of linc-RoR should be
comparable to or higher than miR-145. We therefore used quan-
titative real-time PCR to quantify the exact copy numbers of linc-
RoR and miR-145 per cell (Figure S4C). As a result, we found
that, in the self-renewal hESCs, the expression level of mature
miR-145 was only about 10–20 copies per cell, whereas linc-
ROR level was more than 100 copies per cell. We therefore
suggest that linc-ROR may be able to function as a sponge for
miR-145 in self-renewing hESCs. In differentiated hESCs, miR-
145 significantly increased and was up to more than 500 copies
per cell 7 days postdifferentiation, whereas linc-ROR decreased
to nomore than 20 copies per cell at the same time (Figure S4C).
The sponge effort of linc-RoR may therefore vanish after hESCs
differentiation.
Endogenous linc-RoR Is Essential for the Maintenance
of Core TFs in Self-Renewing hESCs
To further confirm the role of the linc-RoR-mediated regulatory
loop in hESC self-renewal, we used a linc-RoR-specific
shRNA-expressing lentivirus (LV-shROR) to decrease the
expression of linc-RoR in long-term hESCs culture. Three or
7 days after LV-shROR virus infection, we isolated the GFP-posi-
tive (GFP+) hESC H1 population by FACS (Figure 5A). The RNA
level of linc-RoR was found to be decreased by more than
70% at the third and seventh days after LV-shROR infection,
compared with the negative control virus vector LV-NC. Further-
more, we found that the expression levels ofOCT4,NANOG, and
SOX2 mRNA were slightly decreased in linc-RoR-deficient
hESCs after 3 days but were significantly reduced after 7 days
under self-renewal conditions. The expression of mature miR-
145, but not pri- and pre-miR-145, was greatly increased at
the same time (Figure 5B). Similar results were also found in
hES X-01 cells (Figure S5A). Oct4, Nanog, and Sox2 proteins
were also found decreased in LV-shROR-infected cells in an
immunofluorescence analysis (Figure 5C). These results indi-
cated that linc-RoR deficiency results in obvious changes inDthe expression of miR-145 and core TFs in self-renewing hESCs
only after long-term culture. These data are consistent with the
hypothesis that linc-RoR does not directly regulate miR-145
and core TF transcription but instead regulates them through
posttranscriptional fine-tuning.
To assess the role of miR-145 in the linc-RoR-mediated regu-
latory loop, we further employed the miR-145 inhibitor to
abolish miR-145 elevation in linc-RoR-deficient hESCs. The
single-stranded miR-145 inhibitor and negative control RNA
(NC) were transfected into LV-shROR-infected cells one day
after the infection (Figure 5D). After 3 days, the expression of
mature miR-145 was decreased by up to 80% in miR-145
inhibitor-transfected cells, compared with negative controls.
In addition, OCT4 and NANOG mRNA was rescued at up to
80% of the levels in wild-type hESCs after miR-145 inhibitor
transfection.
The linc-RoR-Mediated Regulatory Loop Is Essential for
hESC Self-Renewal
For the linc-RoR-deficient cell phenotype, we found that the
percentage of GFP+ cells in LV-shROR-infected hESCs was
much lower compared with the negative control cells (Figure 5A),
which indicates that linc-RoR knockdown may impair hESC
proliferation. We next investigated, by analyzing the self-renewal
marker SSEA4, whether the maintenance of self-renewal under
normal culturing conditions would be affected by the loss of
linc-RoR. In comparison to the negative control LV-NC, 7 days
of LV-shROR infection caused a significant decrease in the
amount of SSEA4 staining (Figure 5E) in lentiviral GFP-express-
ing cells, as analyzed by flow cytometry. We also employed
a positive control lentivirus that expressed OCT4-shRNA
(shOCT4) (Zaehres and Scho¨ler, 2007). The addition of shOCT4
decreased the self-renewal level significantly, as expected. We
also found changes in cell morphology and decreased alkaline
phosphatase (AP) activity (Figure 5F for H1; Figure S5B for
X-01), which are indicative of differentiation. Furthermore, LV-
shROR culture exhibited a significantly higher apoptosis rate
compared with the negative control LV-NC (Figure S5C), as as-
sayed by apoptosis marker annexin V flow cytometry in lentiviral
GFP-expressing cells. These results suggest that some cells re-
sorted to apoptosis when theywere unable to self-renew. Finally,
a depletion of linc-RoR results in the elevation of the ectodermal
marker SOX1, VIMENTEN, andOTX2, the neural progenitor gene
Nestin, the mesodermal marker Cdx2, HAND1, RUNX2, MIXL1,
and NODAL at mRNA levels. (Figures 5G, S5D, and S5E). We
also confirmed the lineage specific differentiation by immunoflu-
orescence anaslysis. Compared to normal controls, we found
that the linc-RoR-knockdown ESCs highly expressed the ecto-
dermal marker SOX1 and mesodermal marker Cdx2 with
a weak expression of Oct4 and endodermal marker FoxA2 (Fig-
ure 5H). These data further indicate that linc-RoR deficiency may
mainly facilitate hESCs ectodermal and mesodermal differentia-
tion. Interestingly, the phenotypes were similar to miR-145-over-
expression-induced differentiation according to previous reports
(Xu et al., 2009) (Figure S5E). We therefore suggest that knocking
down linc-RoR results in the decline of Oct4, Nanog, and Sox2
expression and the loss of hESC self-renewal.
We further investigated whether miR-145 inhibition could res-
cue the phenotype of linc-RoR-deficient cells. The Oct4- andevelopmental Cell 25, 69–80, April 15, 2013 ª2013 Elsevier Inc. 75
Figure 5. The linc-RoR-Mediated Regula-
tory Loop Is Essential for the Maintenance
of Core TFs and hESC Self-Renewal
(A) The percent of GFP+ hESCs H1 under self-
renewal conditions expressing shRNA targeting
linc-RoR (LV-shROR) or negative control shRNA
(LV-NC) by FACS.
(B) The relative mRNA or miRNA levels in LV-
shROR-infected GFP+ H1 cells referring to LV-
NC-infected cells.
(C) Immunofluorescence analysis to Oct4, Nanog,
and Sox2 proteins. The scale bar represents
100 mm.
(D) The miR-145 inhibitor (inh) rescued the LV-
shROR-mediated reduction of OCT4, SOX2, and
NANOG mRNA in quantitative real-time PCR
assays. The interfering efficiency of miR-145 inh
was confirmed with quantitative real-time PCR. (B
and D) GAPDH or U6 snRNA were used as the
normalization controls. Data are represented as
mean ± SEM. **p < 0.01, n = 3.
(E) The expression levels of SSEA4 in LV-shROR-
infected H1 cells were assayed with flow cy-
tometry. LV-shOct4 was used as a positive
control. The rescue effect of miR-145 inh was also
shown. Data are represented as mean ± SEM.
**p < 0.01, n = 3.
(F) The cell morphology and alkaline phosphatase
(AP) activity quantified by the total areas of AP
positive (AP+) clones for LV-shROR-infected H1
cells and control cells under self-renewal condi-
tions. The rescue effect of miR-145 inh is also
shown. The scale bar represents 100 mm. Data are
represented as mean ± SEM. **p < 0.01, n = 3.
(G) The expression levels of differentiationmarkers
for the three germinal layers in LV-shROR or LV-
NC infected H1 cells and miR-145 inh rescued
cells were confirmed with quantitative real-time
PCR. Data are represented as mean ± SEM.
**p < 0.01, n = 3.
(H) Immunofluorescence analysis to the expres-
sion levels of differentiation markers for the three
germinal layers in LV-shRORor LV-NC infected H1
cells. The scale bar represents 25 mm.
See also Figure S5.
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controls in this analysis. By flow cytometry analysis, we found
an increase in the percentage of SSEA4+ cells (Figure 5E) and
AP activity (Figure 5F) after miR-145 inhibitor or Oct4- and
Nanog-overexpressing vectors transfection, compared with
NC RNA and vector rescued controls. The expression of differ-
entiation markers was also suppressed (Figure 5G). These
results indicate that either miR-145 inhibition or Oct4 and Nanog
overexpression partially rescued the effect of linc-RoR knock-
down in self-renewing hESCs.
Linc-RoR Prevents Core TFs from miR-145-Mediated
Degradation during hESC Differentiation
We next sought to elucidate whether linc-RoR plays a role as
a suppressor of ES differentiation. We transfected a linc-RoR-
encoding lentivirus vector into H1 cells and performed puro-76 Developmental Cell 25, 69–80, April 15, 2013 ª2013 Elsevier Inc.mycin selection to isolate linc-RoR-overexpressing (linc-RoR
OE) cells. The linc-RoR OE cells displayed normal cell
morphology, a high level of linc-RoR mRNA and a low level of
mature miR-145, compared with the vector-transfected cells
under self-renewal conditions (Figures S6A–S6C). Under differ-
entiation conditions, ectopic linc-RoR suppressed the dynamic
reduction of OCT4, NANOG, and SOX2 mRNA expression and
the elevation of miR-145, both of which were found in the control
hESCs during differentiation (Figure 6A). Oct4, Nanog, and Sox2
proteins were also found to maintain at high levels, compared
with control hESCs (Figure 6B). We further investigated the role
of miR-145 and Oct4 during the differentiation of linc-RoR OE
hESCs. We transiently transfected miR-145 mimics or Oct4
siRNA into linc-RoR OE hESCs and then induced the cells to
differentiate by removing bFGF (Figure 6C). After 3 days, the
expression of Oct4 decreased by 60% or 80% in miR-145 or
Figure 6. Linc-RoR Prevents Core TFs from miR-145-Mediated Degradation during hESC Differentiation
(A) The kinetic expression levels of core TFs mRNAs and microRNAs in linc-RoR-overexpressing (linc-RoR OE) hESCs or vector-transfected (vector) hESCs
during differentiation by the withdrawal of bFGF from day 0.
(B) Immunofluorescence analysis to Oct4, Nanog, and Sox2 proteins. The scale bar represents 100 mm.
(C) Inhibition of miR-145 mimics and Oct4 siRNA (siOct4) for the protective efforts of OCT4, SOX2, and NANOG mRNA in the linc-RoR OE hESCs.
(D) The cell morphology and alkaline phosphatase (AP) activity quantified by the total areas of AP positive (AP+) clones for linc-RoR OE hESCs and control cells
under differentiation conditions. The inhibitory efforts of miR-145 and siOct4 are also shown. The scale bar represents 100 mm. Data are represented as
mean ± SEM. **p < 0.01, n = 3.
(E) The mRNA expression levels of self-renewal marker SSEA4 and differentiation markers for the three germinal layers in linc-RoR OE hESCs and control cells
after removing bFGF for 9 days. For (A), (B), and (E), the relative expression levels of RNAwere quantified by quantitative real-time PCR and normalized toGAPDH
or U6 snRNA. Data are represented as mean ± SEM. **p < 0.01, n = 3.
(F) Model for the linc-RoR-related regulatory loop in the modulation of core TFs and hESC pluripotency.
See also Figure S6.
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negative control (NC RNA) (Figure 6C), which indicated that
both the miR-145 mimics and Oct4 siRNA could abolish the
protective effect of ectopic linc-RoR. For 9 days after differenti-
ation, miR-145-induced decreases of core TFs were partiallyDrecovered, whereas siOct4 induced a further decrease of core
TFs (Figure 6C). These data confirm that linc-RoR has a protec-
tive effect and support the hypothesis that linc-RoR overexpres-
sion eliminates mature miR-145 but does not directly increase
Oct4 expression.evelopmental Cell 25, 69–80, April 15, 2013 ª2013 Elsevier Inc. 77
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linc-RoR Functions as a ceRNA in Human ESCIn the phenotype analysis, we found that linc-RoR overexpres-
sion impaired the differentiation of ESCs, compared with the
control cells, as observed by cell morphology, AP straining (Fig-
ure 6D), and the assessment of the suppression of differentiation
markers (Figure 6E). However, hESCs overexpressing linc-RoR
with the mutant miR-145 binding sites (linc-RoR Mut) had
impaired abilities to suppress hESC differentiation, compared
to hESCs overexpressing wild-type linc-RoR (Figure S6D). These
results indicate that the ectopic expression of linc-RoR prevents
ESCs from differentiation mainly through a miR-145-related
mechanism. Furthermore, we also found that the AP-positive
clones and SSEA4 expression levels were significantly
decreased after miR-145 or Oct4 siRNA transfection, whereas
the levels of differentiation markers increased at the same time
(Figure 6E). The Oct4 siRNA much more strongly abolished the
efforts of linc-RoR overexpression, compared with miR-145
mimics, which also confirmed that ectopic linc-RoR protects
core TFs through a direct suppression of miR-145 during hESC
differentiation.
We also investigated the differentiation process of linc-RoR-
deficient hESCs and found that the levels of core TF mRNA
rapidly declined, whereas mature miR-145 rapidly increased in
linc-RoR-deficient hESCs after bFGF removal, compared with
LV-NC-infected hESCs, as observed by quantitative real-time
PCR assays (Figure S6E). These results further confirmed that
endogenous linc-RoR functions as a ceRNA of core TFs and
that hESCs were facilitated to differentiate in the absence of
linc-RoR.
DISCUSSION
MicroRNAs have been identified as essential posttranscriptional
modulators, which facilitate the rapid clearance of core TFs tran-
scripts during hESC differentiation (Neveu et al., 2010). However,
recent developments have presented a new twist; targets can
also reciprocally control the level and function of miRNAs (Pas-
quinelli, 2012). But such miRNA regulators remain undefined in
human pluripotent cells by far. Herein, our data indicate that
linc-RoR functions as an endogenous miRNA sponge for differ-
entiation-related miRNAs. In self-renewing hESCs, linc-RoR
was expressed at a high level and removed trace transcribed
miRNAs when hESCs were subjected to temporary and slight
differentiation agents. These observations are supported by
the fact that slightly differentiated hESCs can be rescued to
a self-renewing state. However, linc-RoR was only a competing
suppressor, as it could be consumed when hESCs were under
strong differentiation conditions in which abundant miRNAs
were transcribed. This characteristic of linc-RoR is important
for the reduction of core TFs and miRNAs elevation during the
early phase of hESC differentiation, which permits further differ-
entiation of hESCs.
Additionally, our current work represents a detailed charac-
terization of any lincRNA functions as a ceRNA to protect
core TFs in self-renewing hESCs. LincRNAs are emerging as
key regulators in early development (Pauli et al., 2011; Ponting
et al., 2009) and are required for the pluripotency of hESCs
(Bertani et al., 2011; Sheik Mohamed et al., 2010) and for the
reprogramming of somatic cells (Loewer et al., 2010). In the
most recently established models, lincRNAs function to interact78 Developmental Cell 25, 69–80, April 15, 2013 ª2013 Elsevier Inc.with chromatin-modifying complexes to assist in the regulation
of the distinct epigenetic architecture and to impart target
specificity in the control of pluripotency (Bertani et al., 2011;
Mondal and Kanduri, 2012; Ponting et al., 2009). However,
our data indicate a model of miRNA/lincRNA interactions in
pluripotent cells. Considering the multiple targets of miRNAs,
we also hypothesize that there may be many other lincRNAs
that function as ceRNAs to regulate key genes expression
in hESCs. The identification of these ceRNAs may promote
the understanding of early development and many related
diseases.
Furthermore, we put forward a regulatory feedback loop
model, which integrates a transcriptional and posttranscriptional
network, for the maintenance of self-renewal. Our data indicate
that endogenous linc-RoR prevents core TFs by reduction of
their suppressing miRNAs. Interestingly, as Loewer et al. (2010)
previously reported and we confirmed, linc-RoR transcription
was mainly controlled by the core TFs Oct4, Sox2, and Nanog.
We therefore suggest that linc-RoR, miRNAs, and the core TFs
form a regulatory circuit consisting of autoregulatory and dual-
negative feedback loops during ESC self-renewal. This regula-
tory loop maintains a relative balance in self-renewing hESCs
to resist slight environmental changes and to elicit a rapid
response to strong differentiation signals that promote hESCs
differentiation. We also hypothesize that linc-RoR-mediated
loop contributes to somatic-cell reprogramming. Many miRNAs
have been proven to serve as endogenous reprogramming
barriers in somatic cells (Choi et al., 2011; Mallanna and Rizzino,
2010), for example, miR-34 (Choi et al., 2011), which was pre-
dicted under the regulation of linc-RoR in our works. We hypoth-
esized that ectopic expression of core TFs strongly promotes
endogenous linc-RoR expression, which may remove these
core TF-suppressing miRNAs and facilitates endogenous core
TF expression. This model may provide insights into the tran-
scriptional regulation of stem cells and reveal how Oct4, Sox2,
and Nanog maintain a stable high level during ESCs self-renewal
and iPSCs formation.
Lastly, linc-RoR was previously identified as a ‘‘regulator of
reprogramming,’’ which mainly promotes the emergence of
iPSC, as its expression was elevated in iPSCs, compared
with ESCs. However, despite its changes and functions in the
artificial processes, we also showed that endogenous linc-
RoR plays a key role in the ESC maintenance, which may
have important physiological functions in early development
and further implications in developmental biology studies and
clinical applications. The expression of linc-RoR may also be
a potential self-renewal and pluripotency marker for hESCs
as its expression rapidly decreased under the differentiation
conditions, even prior to the decline in levels of these core
TFs. Additionally, it may also be interesting to imagine that
the ectopic linc-RoR could be utilized to modulate the self-
renewal state of in-vitro-cultured stem cells, which may facili-
tate related studies and cell therapies. Furthermore, consid-
ering the widespread expression of Oct4, Nanog, and Sox2,
among other types of stem cells even and tumor cells (Bunaciu
and Yen, 2011; Jeter et al., 2011; Pardo et al., 2010), linc-RoR
may also contribute to the regulation of genetic networks
during development and tissue regeneration and may lead to
new therapies for many diseases.
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Cell Culture
hESCs (H1 and X-01) were obtained from Prof. Xiao (Zhejiang University, Zhe-
jiang, China) and cultured under feeder-free conditions in accordance with the
protocol from the WiCell Research Institute. Differentiation by forming EB
suspension was carried out in hESC medium without bFGF. An alternative
differentiation method of feeder-free hESCs involved the use of noncondi-
tioned hESC medium deprived of bFGF. BMP4 differentiation was done with
a daily dose of 50 ng/ml BMP4 (R&D Systems, Minneapolis) in hESC medium
without bFGF for 7 days.
Immunofluorescence and Fluorescent In Situ Hybridization
These assays were preformed according to previous reports (Xu et al., 2009).
For the detection of proteins, anti-Nanog, anti-Oct4, anti-Sox2, anti-Sox1,
anti-Cdx2, and anti-FoxA2 (all from Abcam, Cambridge) were used. For the
detection of lincRNA, RNA probes were used and labeled with digoxigenin
(DIG)-UTP (Roche, Indianapolis, IN, USA) using the mMESSAGE T7 Ultra
In Vitro Transcription Kit (Ambion, Carlsbad, CA, USA) in accordance with
the manufacturer’s directions.
Lentiviral Transduction, Vectors, and RNA Oligos Transfection in
hESCs
Human ESC colonies were grown on matrigel-coated 6-well plates. Lentivirus
transduction for cell cluster was performed according to previously described
protocols (Gropp and Reubinoff, 2006). Fugene HD reagent (Promega, Madi-
son, WI, USA) or lipofectamine RNAiMAX (Invitrogen, Carlsbad, WI, USA) was
used for vector or RNA oligos transfection, respectively, in accordance with
the manufacturer’s instructions.
Luciferase Reporter Transfection and Dual Luciferase Assay
Luciferase reporter transfection and dual luciferase assay was preformed ac-
cording to previous reports (Xu et al., 2009). The details of construction of
reporter vectors and transfections are shown in the Supplemental Experi-
mental Procedures.
FACS and Flow Cytometry Analysis
FACS and flow cytometry analysis were performed according to previous
reports (Xu et al., 2009). For self-renewal analysis, each 100 ml of cell suspen-
sion (1–5 3 105 cells) was incubated with the primary antibody mouse anti-
SSEA4 (Cell Signaling Technology, Danvers, MA, USA) and PE-conjugated
goat anti-mouse (Jackson ImmunoResearch, West Grove, PA, USA). For
apoptosis analysis, 1–53 105 cells from each sample were processedwith an-
nexin V-PE (Annexin V-PE Apoptosis Detection Kit, BioVision, Milpitas, CA,
USA), in accordance with the manufacturer’s instructions.
RNA Isolation and Real-Time PCR Analysis
Total RNA was extracted using Trizol (Invitrogen). The miRNA levels were as-
sayed with Taqman probes and primer sets (Applied Biosystems, Foster City,
CA, USA) in accordance with the manufacturer’s instructions. For mRNA anal-
ysis, the first-strand complementary DNA (cDNA) was generated with random
primers for real-time PCR using a Power SYBR Green PCR Master Mix
(Applied Biosystems) protocol in a StepOne Plus System (Applied
Biosystems).
ChIP and RIP Assay
ChIP assays were performed in accordance with the manufacturer’s instruc-
tions of the EZ-Magna ChIP A/G Kit (Millipore, Billerica, MA, USA). The
MS2bp-MS2bs-based RIP assay was performed according to previous
reports (Gong and Maquat, 2011), with modifications for using the EZ-Magna
RIP Kit (Millipore) in accordance with the manufacturer’s instructions.
Statistical Analysis
Data are presented as mean ± SEM. For data from quantitative real-time PCR,
WB, luciferase activity, and AP+ colonies area, statistical comparisons
between experimental groups were analyzed with ANOVA and Fisher’s exact
test or two-tailed Student’s t test. p < 0.01 was taken to indicate statistical
significance.DA more detailed version of the procedures is included in the Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.devcel.2013.03.002.
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